Insider Trading & Ownership of GV 2019 GP, L.L.C.

Location: Mountain View, CA
Summary: The estimated net worth of GV 2019 GP, L.L.C. is at least $322,990,588 dollars as of 18 May 2026. GV 2019 GP, L.L.C. is the 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $177.59M. GV 2019 GP, L.L.C. is the Former 10% Group Member of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $60.21M. GV 2019 GP, L.L.C. is the 10%+ Owner of Verve Therapeutics, Inc. and owns shares of Verve Therapeutics, Inc. stock worth about $44.73M. GV 2019 GP, L.L.C. is the 10%+ Owner of Ethos Technologies Inc. and owns shares of Ethos Technologies Inc. (LIFE) stock worth about $40.46M.
Signature: /s/ Kim Burr, Authorized Signatory of GV 2019 GP, L.L.C.
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow GV 2019 GP, L.L.C. and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

GV 2019 GP, L.L.C. has 4 issuer positions tracked on this page.
Estimated disclosed ownership value: $322,990,588.
Recent insider filing activity is available below.

Change

Largest disclosed position: Prime Medicine, Inc. ($177,594,643).
Past-year value change for that position: .

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.